Amedisys (AMED): Long ahead of earnings. Amedisys Inc. provides home health and hospice services to the chronic, co-morbid, and aging American population. Revenue for Amedisys went from just $142 million in 2004 to $1.187 billion in 2008, as net income went from just $8.4 million to $86.682 million in the same time frame. 8,000 Americans will become Medicare eligible each day beginning in 2011, and by 2030, 57.8 million baby boomers will be eligible for Medicare benefits—as of 2008, Inpatient Hospitals account for 29% of total Medicare benefit outlays by service---which has AMED written all over it. With the company forecasting $1.425 to $1.475 billion in revenue for 2009 on EPS of $4.10 to $4.30 and a mammoth short position of 38.00%, shares of Amedisys are going higher. It is also worth noting that Amedisys has beaten analyst estimates the past 7 quarters in a row!

Scotts Miracle-Gro (SMG): Short ahead of earnings. Everyone knows Scotts Miracle-Gro (SMG), which manufactures, and markets, the sale of lawn and garden care products in the US and EU. Scott’s principal line of sales come from their granular lawn fertilizer and combination products, which includes fertilizer and crabgrass control, weed control, pest control products and plant foods. For the full-year of 2008 Scott’s net sales were $2.9 billion, which is broken down as follows: 75 percent global consumer, 12 percent global professional, 8 percent Scott’s lawn service, 5 percent Smith & Hawken. Net sales went from $2.87 billion in 2007 to $2.98 billion in 2008---a 3.83 percent increase, while gross profit actually declined going from $1.004 billion in 2007 to just 939.6 million in 2008, a year-over-year decline of 10.56.

No Analysis added

No Analysis added

No Analysis added

No Analysis added

No Analysis added

No Analysis added